Integrin α9β1 mediates enhanced cell migration through nitric oxide synthase activity regulated by Src tyrosine kinase

Por Gupta, Shiv K., Vlahakis, Nicholas E.
Publicado em 2009

Integrin α9β1: Unique signaling pathways reveal diverse biological roles

Por Gupta, Shiv K., Vlahakis, Nicholas E.
Publicado em 2010

Vascular Endothelial Growth Factor A (VEGF-A) Induces Endothelial and Cancer Cell Migration through Direct Binding to Integrin α9β1: IDENTIFICATION OF A SPECIFIC α9β1 BINDING SITE...

Por Oommen, Saji, Gupta, Shiv K., Vlahakis, Nicholas E.
Publicado em 2011

Scientific method optimizing applied research decisions /

Por Ackoff, Russell Lincoln, Gupta, Shiv K., Minas, J. Sayer.
Publicado em 1962

Scientific method optimizing applied research decisions /

Por Ackoff, Russell Lincoln, Gupta, Shiv K., Minas, J. Sayer.
Publicado em 1962.

Long non-coding RNA profile in mantle cell lymphoma identifies a functional lncRNA ROR1-AS1 associated with EZH2/PRC2 complex

Por Hu, Guangzhen, Gupta, Shiv K., Troska, Tammy P., Nair, Asha, Gupta, Mamta
Publicado no Oncotarget (2017)

Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition

Por Gupta, Shiv K, Oommen, Saji, Aubry, Marie-Christine, Williams, Brian P., Vlahakis, Nicholas E
Publicado em 2012

A novel design for porphyrin based D–s–A systems as molecular rectifiers

Por Garg, Kavita, Majumder, Chiranjib, Gupta, Shiv K., Aswal, Dinesh Kumar, Nayak, Sandip Kumar, Chattopadhyay, Subrata
Publicado no Chem Sci (2016)

Non-Smad Transforming Growth Factor-β Signaling Regulated by Focal Adhesion Kinase Binding the p85 Subunit of Phosphatidylinositol 3-Kinase

Por Hong, Min, Wilkes, Mark C., Penheiter, Sumedha G., Gupta, Shiv K., Edens, Maryanne, Leof, Edward B.
Publicado em 2011

Vascular Endothelial Growth Factors C and D Induces Proliferation of Lymphangioleiomyomatosis Cells through Autocrine Crosstalk with Endothelium

Por Issaka, Rachel B., Oommen, Saji, Gupta, Shiv K., Liu, Gang, Myers, Jeffrey L., Ryu, Jay H., Vlahakis, Nicholas E.
Publicado em 2009

Discordant in vitro and in vivo chemo-potentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts

Por Gupta, Shiv K., Mladek, Ann C., Carlson, Brett L., Boakye-Agyeman, Felix, Bakken, Katrina, Kizilbash, Sani, Schroeder, Mark A., Reid, Joel, Sarkaria, Jann N.
Publicado em 2014

Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases

Por Andrianifahanana, Mahefatiana, Wilkes, Mark C., Gupta, Shiv K., Rahimi, Rod A., Repellin, Claire E., Edens, Maryanne, Wittenberger, Joshua, Yin, Xueqian, Maidl, Elizabeth, Becker, Jackson, Leof, Edward B.
Publicado em 2013

Design and characterization of an economical (192)Ir hemi-brain small animal irradiator

Por Grams, Michael P., Wilson, Zachary C., Sio, Terence T., Beltran, Chris J., Tryggestad, Erik J., Gupta, Shiv K., Blackwell, Charles R., McCollough, Kevin P., Sarkaria, Jann N., Furutani, Keith M.
Publicado no Int J Radiat Biol (2014)

Inhibiting DNA-PK(CS) Radiosensitizes Human Osteosarcoma Cells

Por Mamo, Tewodros, Mladek, Ann C., Shogren, Kris L., Gustafson, Carl, Gupta, Shiv K., Riester, Scott M., Maran, Avudaiappan, Galindo, Mario, van Wijnen, Andre J., Sarkaria, Jann N., Yaszemski, Michael J.
Publicado no Biochem Biophys Res Commun (2017)

Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of G...

Por Laramy, Janice K., Kim, Minjee, Gupta, Shiv K., Parrish, Karen E., Zhang, Shuangling, Bakken, Katrina K., Carlson, Brett L., Mladek, Ann C., Ma, Daniel J., Sarkaria, Jann N., Elmquist, William F.
Publicado no J Pharmacol Exp Ther (2017)

Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts()

Por Kitange, Gaspar J., Mladek, Ann C., Carlson, Brett L., Schroeder, Mark A., Pokorny, Jenny L., Cen, Ling, Decker, Paul A., Wu, Wenting, Lomberk, Gwen A., Gupta, Shiv K., Urrutia, Raul A., Sarkaria, Jann N.
Publicado em 2012

Restricted delivery of talazoparib across the blood-brain barrier limits the sensitizing effects of poly (ADP-ribose) polymerase inhibition on temozolomide therapy in glioblastoma

Por Kizilbash, Sani H., Gupta, Shiv K., Chang, Kenneth, Kawashima, Ryo, Parrish, Karen E., Carlson, Brett L., Bakken, Katrina K., Mladek, Ann C., Schroeder, Mark A., Decker, Paul A., Kitange, Gaspar J., Shen, Yuqiao, Feng, Ying, Protter, Andrew A., Elmquist, William F., Sarkaria, Jann N.
Publicado no Mol Cancer Ther (2017)

The efficacy of the Wee1 inhibitor MK-1775 combined with temozolomide is limited by heterogeneous distribution across the blood-brain barrier in glioblastoma

Por Pokorny, Jenny L., Calligaris, David, Gupta, Shiv K., Iyekegbe, Dennis O., Mueller, Dustin, Bakken, Katrina K., Carlson, Brett L., Schroeder, Mark A., Evans, Debra L., Lou, Zhenkun, Decker, Paul A., Eckel-Passow, Jeanette E., Pucci, Vincenzo, Ma, Bennett, Shumway, Stuart D., Elmquist, William, Agar, Nathalie Y., Sarkaria, Jann N.
Publicado no Clin Cancer Res (2015)

Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma

Por Gupta, Shiv K., Kizilbash, Sani H., Carlson, Brett L., Mladek, Ann C., Boakye-Agyeman, Felix, Bakken, Katrina K., Pokorny, Jenny L., Schroeder, Mark A., Decker, Paul A., Cen, Ling, Eckel-Passow, Jeanette E., Sarkar, Gobinda, Ballman, Karla V., Reid, Joel M., Jenkins, Robert B., Verhaak, Roeland G., Sulman, Erik P., Kitange, Gaspar J., Sarkaria, Jann N.
Publicado no J Natl Cancer Inst (2015)

Targeted Therapies for Glioblastoma: A Critical Appraisal

Publicado em 2020